(Q46655345)

24 December 2017

title

Retroviral replicating vectors in cancer (English)

1 reference

24 December 2017

Christopher R Logg

1

0 references

author name string

Joan M Robbins

2

1 reference

24 December 2017

Douglas J Jolly

3

1 reference

24 December 2017

Harry E Gruber

4

1 reference

24 December 2017

Noriyuki Kasahara

5

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 January 2012

1 reference

24 December 2017

published in

Methods in Enzymology

1 reference

24 December 2017

volume

507

1 reference

24 December 2017

page(s)

199-228

1 reference

24 December 2017

Use of replication-competent retroviral vectors in an immunocompetent intracranial glioma model

cites work

1 reference

12 December 2020

In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies

1 reference

12 December 2020

Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus

1 reference

12 December 2020

Clinical development of experimental virus-mediated gene therapy for malignant glioma.

1 reference

12 December 2020

Tissue- and tumor-specific targeting of murine leukemia virus-based replication-competent retroviral vectors

1 reference

12 December 2020

A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors

1 reference

12 December 2020

Naturally occurring humoral immunity to endogenous xenotropic and amphotropic type-C virus in the mouse

1 reference

12 December 2020

Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors

1 reference

12 December 2020

Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene

1 reference

12 December 2020

The interface between the innate interferon response and expression of host retroviral restriction factors

1 reference

12 December 2020

Cancer despite immunosurveillance: immunoselection and immunosubversion

1 reference

12 December 2020

Searching for a cure: gene therapy for glioblastoma

1 reference

12 December 2020

Cancer gene therapy: fringe or cutting edge?

1 reference

12 December 2020

Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus

1 reference

12 December 2020

CNS metastasis: an old problem in a new guise

1 reference

12 December 2020

Impaired interferon signaling is a common immune defect in human cancer

1 reference

12 December 2020

The polarization of immune cells in the tumour environment by TGFbeta

1 reference

12 December 2020

Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance

1 reference

12 December 2020

Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors

1 reference

12 December 2020

Oncolytic virotherapy reaches adolescence

1 reference

12 December 2020

Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary

1 reference

12 December 2020

A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent

1 reference

12 December 2020

Host factors involved in resistance to retroviral infection

1 reference

12 December 2020

Retrovirus-mediated gene transfer to tumors: utilizing the replicative power of viruses to achieve highly efficient tumor transduction in vivo

1 reference

12 December 2020

A Pitfall of the 3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethonyphenol)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay due to evaporation in wells on the edge of a 96 well plate

1 reference

12 December 2020

Immune response to Moloney-murine leukemia virus-induced antigens in bone marrow.

1 reference

12 December 2020

The emerging fields of suicide gene therapy and virotherapy.

1 reference

12 December 2020

Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts.

1 reference

12 December 2020

Therapeutic efficacy of replication-competent retrovirus vector-mediated suicide gene therapy in a multifocal colorectal cancer metastasis model

1 reference

12 December 2020

Replication-competent Moloney murine leukemia virus carrying a bacterial suppressor tRNA gene: selective cloning of proviral and flanking host sequences

1 reference

12 December 2020

Effects of Adoptive Immune Transfers on Murine Leukemia Virus-Infection of Rats

1 reference

12 December 2020

Cell-to-cell transmission of retroviruses: Innate immunity and interferon-induced restriction factors

1 reference

12 December 2020

Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts

1 reference

12 December 2020

History of oncolytic viruses: genesis to genetic engineering

1 reference

12 December 2020

Replicative retroviral vectors for cancer gene therapy

1 reference

12 December 2020

Comparative evaluation of preclinical in vivo models for the assessment of replicating retroviral vectors for the treatment of glioblastoma

1 reference

12 December 2020

Optimization of enzyme-substrate pairing for bioluminescence imaging of gene transfer using Renilla and Gaussia luciferases

1 reference

12 December 2020

Integration of murine leukemia virus DNA depends on mitosis

1 reference

12 December 2020

Tumor-selective gene expression in a hepatic metastasis model after locoregional delivery of a replication-competent retrovirus vector

1 reference

12 December 2020

Adaptation of chimeric retroviruses in vitro and in vivo: isolation of avian retroviral vectors with extended host range

1 reference

12 December 2020

Adaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicing.

1 reference

12 December 2020

The maturation of human gene therapy

1 reference

12 December 2020

Mechanisms of retroviral mutation

1 reference

12 December 2020

Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors

1 reference

12 December 2020

Inserting a nuclear targeting signal into a replication-competent Moloney murine leukemia virus affects viral export and is not sufficient for cell cycle-independent infection

1 reference

12 December 2020

Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma

1 reference

12 December 2020

Gene therapy for glioblastoma.

1 reference

12 December 2020

Clinical development directions in oncolytic viral therapy

1 reference

12 December 2020

Construction and recovery of viable retroviral genomes carrying a bacterial suppressor transfer RNA gene

1 reference

12 December 2020

Tissue-specific transcriptional targeting of a replication-competent retroviral vector

1 reference

12 December 2020

Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors

1 reference

12 December 2020

Recent clinical experience with oncolytic viruses.

1 reference

12 December 2020

10.1016/B978-0-12-386509-0.00011-9

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017